We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
A comprehensive guide to Xgeva (denosumab) for cancer patients in India, covering its uses, administration, side effects, and precautions.

Cancer treatment can be a complex journey, and managing its effects on the body is crucial for maintaining quality of life. For patients in India dealing with certain types of cancer or tumors, Xgeva, a medication containing denosumab, plays a significant role in preventing serious bone-related complications. This comprehensive guide aims to provide clear, practical information about Xgeva, its uses, potential side effects, and what patients in India need to know.
Xgeva is a prescription medication that belongs to a class of drugs called RANKL inhibitors. It is administered as an injection under the skin, typically at a clinic or doctor's office. The active ingredient, denosumab, works by targeting a protein called RANKL, which is involved in the process of bone breakdown. By inhibiting RANKL, Xgeva helps to slow down the excessive bone resorption that can occur in certain cancer-related conditions, thereby strengthening bones and reducing the risk of fractures and other skeletal issues.
Xgeva is prescribed for adults with specific cancer types or bone tumors to achieve several critical goals:
In some specific cases, Xgeva may also be prescribed for certain children diagnosed with giant cell tumors of bone.
Xgeva is given as a subcutaneous injection, meaning it is injected just under the skin. In India, this is usually done by a healthcare professional at a hospital, clinic, or doctor's office. The standard dosage is typically 120 milligrams (mg) administered every four weeks. It is essential to adhere strictly to the prescribed schedule to ensure the medication's effectiveness.
Like all medications, Xgeva can cause side effects, ranging from mild to serious. It's important for patients to be aware of these and to communicate any concerns with their healthcare provider.
These side effects are generally manageable and may improve over time:
If any of these mild side effects become persistent or bothersome, consulting with a doctor or pharmacist is recommended.
While less common, serious side effects require immediate medical attention. These can include:
Immediate Medical Attention:
General Precautions:
Xgeva (denosumab) is a biologic drug and is not available in a biosimilar form in India. This means it is only available as the brand-name drug Xgeva. It belongs to a specific class of medications (RANKL inhibitors) and is distinct from other bone-modifying agents like bisphosphonates, although they share similar goals in managing bone health in cancer patients. Your oncologist will determine the most appropriate treatment plan based on your specific condition, cancer type, and overall health.
Managing cancer and its treatments requires a holistic approach. Patients undergoing Xgeva therapy should focus on:
The duration of Xgeva treatment depends on the specific type of cancer, the stage of the disease, and how your body responds to the medication. Your oncologist will determine the optimal treatment duration for you.
It is crucial to inform your doctor about any pre-existing kidney conditions. While Xgeva is generally considered safe for patients with kidney issues, your doctor will monitor your kidney function and adjust treatment if necessary.
If you miss an appointment for your Xgeva injection, contact your doctor's office as soon as possible to reschedule. Do not try to self-administer or adjust the schedule without medical advice.
While there are no strict dietary restrictions specifically for Xgeva, maintaining adequate calcium and Vitamin D intake is important for bone health. Your doctor will advise you on the best way to ensure sufficient intake, especially if you are undergoing other cancer therapies that might affect nutrient absorption or levels.
Both Xgeva and Prolia contain denosumab. However, they are prescribed for different conditions and at different dosages. Xgeva is used for cancer-related bone issues and giant cell tumors, while Prolia is primarily used to treat osteoporosis (weakening of bones) in postmenopausal women and men.
Xgeva (denosumab) is a valuable medication for managing bone health in cancer patients in India. By understanding its uses, potential side effects, and the importance of adhering to medical advice, patients can better navigate their treatment journey. Always maintain open communication with your healthcare team for personalized guidance and support.
Learn about potential side effects of CML treatments like TKIs, interferon, chemotherapy, and stem cell transplants. Understand what to expect and how to communicate with your doctor for effective management.
April 1, 2026

Discover essential support resources, financial aid options, and community connections for individuals navigating life with Chronic Myeloid Leukemia (CML). Find practical advice and empathetic guidance.
April 1, 2026
Explore targeted therapy for multiple myeloma. Learn how these precision treatments work, their types, potential side effects, and how they're used alongside other therapies to manage this blood cancer.
April 1, 2026